Haemonetics (HAE) Tops Q1 EPS by 17c, Revenues Beat
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $90.27 --0%
Financial Fact:
Other income/(expense), net: -1.96M
Today's EPS Names:
HSAI, SYRS, EGRX, More
Financial Fact:
Other income/(expense), net: -1.96M
Today's EPS Names:
HSAI, SYRS, EGRX, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q1 EPS of $0.59, $0.17 better than the analyst estimate of $0.42. Revenue for the quarter came in at $229.3 million versus the consensus estimate of $219.95 million.
GUIDANCE:
Haemonetics sees FY2019 EPS of $2.00-$2.30, versus the consensus of $2.17.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Eltek Ltd (ELTK) Reports Q2 EPS of $0.41
- uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
